DaVita (DVA)
(Delayed Data from NYSE)
$132.52 USD
+4.70 (3.68%)
Updated Apr 22, 2024 04:00 PM ET
After-Market: $132.55 +0.03 (0.02%) 7:58 PM ET
3-Hold of 5 3
A Value C Growth D Momentum B VGM
Industry / Sector Report
Industry : Medical - Outpatient and Home Healthcare
Zacks Industry Rank
Bottom 38% (156 out of 252)Zacks Sector Rank
Top 25% (4 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 2.86 | 1.68 | 9.99 |
Current Quarter Estimate | 1.96 | 0.69 | 60.00 |
Year Ago Quarter Estimate | 1.58 | 1.31 | 52.54 |
Next Quarter Estimate | 2.45 | 0.72 | 61.00 |
Next Year Estimate | 10.01 | 5.93 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 8.97 | 11.50 | 17.08 |
Next Year | 8.45 | 17.20 | 8.00 |
Last 5 Years | 15.50 | 6.50 | 8.10 |
Next 5 Years | 12.10 | 11.30 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 15.81 | 13.83 |
Price/Book (MRQ) | 9.73 | 2.28 |
Price/Cash Flow (MRFY) | 7.89 | 12.17 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | 5.70% | -88.48% |
Return on Equity (TTM) | 64.42% | -50.54% |
Debt to Equity (MRQ) | NA | 0.29 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.